Article Text

PDF
Asthma admission rates and patterns of salbutamol and inhaled corticosteroid prescribing in England from 2013 to 2017
  1. Sherif Gonem1,2,
  2. Andrew Cumella3,
  3. Matthew Richardson2
  1. 1 Department of Respiratory Medicine, Nottingham City Hospital, Nottingham, UK
  2. 2 Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK
  3. 3 Asthma UK, London, UK
  1. Correspondence to Dr Sherif Gonem, Department of Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK; sg330{at}le.ac.uk

Abstract

Asthma exacerbations are a common reason for hospital admission. We sought to identify whether patterns of inhaler prescribing are significantly associated with regional asthma admission rates. Asthma admission rates were obtained for English Clinical Commissioning Group (CCG) regions from 2013/2014 to 2016/2017. Raw prescribing data were obtained from OpenPrescribing.net, based on monthly general practice-level data published by the National Health Service Business Services Authority. Data were analysed using a linear mixed effects model. The ratio of salbutamol to inhaled corticosteroid prescriptions within a CCG was positively associated with asthma admission rates, independently of median age, asthma prevalence and socioeconomic deprivation.

  • asthma In primary care

Statistics from Altmetric.com

Footnotes

  • Patient consent for publication Not required.

  • Contributors SG: conceived the idea, obtained the data, undertook statistical analysis and wrote the manuscript; AC: provided the asthma admissions data and critically reviewed the manuscript; MR: undertook statistical analysis.

  • Funding This paper presents independent research funded by the National Institute for Health Research (NIHR). SG was funded by an NIHR Clinical Lectureship.

  • Disclaimer The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.